Omni’s complex medical consumables serve as core products for medical device manufacturers. Credit: kalhh from Pixabay.

Aterian Investment Partners’ portfolio company Vander-Bend Manufacturing has completed the acquisition of US-based precision manufacturer and service provider Omni Components (Omni) for an undisclosed sum.

Based in Hudson, New Hampshire, Omni offers tight-tolerance consumable medical products for use in spinal, cardiovascular and tendon-related surgeries.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Omni CEO and owner Frank Stone said: “This partnership will continue the vision of Omni that we have built over many years. It is clear that both Omni and Vander-Bend have developed and refined through the years a strong culture of producing state-of-the-art products for our customers.”

The company is engaged in the production of complex medical consumables to cater to major medical device manufacturers.

Prototyping, vertical milling, CNC Swiss machining, turnkey solutions and wire/RAM EDM are some of the core capabilities of the company.

The acquisition is expected to help Vander-Bend to bolster its capabilities besides expanding its manufacturing footprint to the Northeast and Southwest.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The expansion will complement the company’s existing manufacturing base in the West Coast, Midwest and Southeast regions.

Vander-Bend CEO Greg Biggs said: “We are strong believers in the growth prospects of Omni and look forward to working with the Omni team to continue to provide a wide breadth of capabilities to the company’s blue-chip customer base.

“With our partnership, Vander-Bend will also expand its medical commercial relationships, allowing us to better serve our customers and continue our growth trajectory.” 

Vander-Bend has acquired four medical technology businesses, including Omni, since the acquisition of Aterian in May 2018.

The company also established and commercialised three new manufacturing facilities, as well as the completion of an expansion of capital equipment.

Vander-Bend currently has nine facilities across the US and employs a workforce of more than 1,200 people.